WallSt.net Interviews Chairman of Efoodsafety.com Inc., CEO of Cel-Sci Corp., President and CEO of Epimmune Inc. and President and COO of Cardima Inc.


NEW YORK, Oct. 15, 2003 (PRIMEZONE) -- Clarence Karney, Chairman of Efoodsafety.com Inc. (OTCBB:EFSF) discussed the company's niche market in an often neglected sector of an $800 billion industry. Karney discussed current food safety regulations, and how his company's patented Food Safe 2600 process sanitizes produce, meat and poultry far beyond current FDA and USDA standards. Karney estimated the company could grow to $200 million in 2006, and detailed the company's projected growth profile in the interview. Efoodsafety.com Inc.'s stock has risen from $0.45 to $1.90 since it began trading in early Sept. 2003.

To hear the entire interview, visit www.wallst.net.

Geert Kersten, CEO of Cel-Sci Corp. (AMEX:CVM) discussed how the company is working diligently to change a major paradigm for cancer, and infectious disease therapy. He detailed Cel-Sci's CEL-1000 product, and how the company has plans to bring the product to market as soon as possible. Kersten covered various aspects of the company's operations, including product timelines, testing results, and recent government grants. Looking to the future, Kersten said, "I don't know what is going to happen, but I have a feeling it's going to be something big."

To hear the entire interview, visit www.wallst.net

Dr. Emile Loria, President and CEO of Epimmune Inc. (Nasdaq:EPMN) discussed how the company's approach to battling cancer and infectious diseases differs from their competitors. One of the major differences highlighted was the company's use of epitopes, which Loria detailed. Other topics Loria covered were the recent grants the company received from the NIH and the NAID, including a recent $500,000 addendum to their contract with the NIH to include smallpox as a target for Epimmune's epitope-based vaccines.

To hear the entire interview, visit www.wallst.net.

William Wheeler, President and COO of Cardima Inc. (Nasdaq:CRDM) discussed how the company is planning to bounce back from the recent recommendation against the approval company's Revelation Tx micro catheter system at a panel hearing. Wheeler discussed the product's European market penetration, and the size of the product's marketplace. Other topics covered were the company's different revenue streams, upcoming milestones, and three to five year outlook.

To hear the entire interview, visit www.wallst.net.

About www.wallst.net

www.wallst.net is owned and operated by Digital Wall Street Inc., a multimedia provider of original, insightful commentary and news from North America's leading companies, giving a direct link to the management of today's fastest-growing companies through encompassing executive interviews and Sector Seminars. The company offers both a free service to consumers, and a premium, paid, monthly subscription to its members. Digital Wall Street Inc. is being compensated by a third party for the dissemination of this release, press, and promotional materials. Ventana Consulting Ltd. has entered into an agreement to compensate Digital Wall Street with 50,000 shares of eFoodsafety.com Inc.'s stock (OTCBB:EFSF) valued at $25,000 for three months of services. Digital Wall Street reserves the right to sell their stock of EFSF at any time. For a complete list of our business relationships, visit www.wallst.net/disclaimer.asp.


            

Tags


Contact Data